Your browser doesn't support javascript.
loading
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.
Kim, Tae Won; Burris, Howard A; de Miguel Luken, Maria J; Pishvaian, Michael J; Bang, Yung-Jue; Gordon, Michael; Awada, Ahmad; Camidge, D Ross; Hodi, F Stephen; McArthur, Grant A; Miller, Wilson H; Cervantes, Andres; Chow, Laura Q; Lesokhin, Alexander M; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang-Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian L.
Affiliation
  • Kim TW; Asan Medical Center, University of Ulsan, Seoul, Korea.
  • Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee.
  • de Miguel Luken MJ; START-CIOCC, Hosp. HM Sanchinarro, Madrid, Spain.
  • Pishvaian MJ; Johns Hopkins University School of Medicine, Washington, DC.
  • Bang YJ; Seoul National University College of Medicine, Seoul, Korea.
  • Gordon M; HonorHealth Research Institute, Scottsdale, Arizona.
  • Awada A; Jules Bordet Institute, Brussels, Belgium.
  • Camidge DR; University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Hodi FS; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.
  • Miller WH; Jewish General Hospital and Segal Cancer Centre, McGill University, Montréal, Canada.
  • Cervantes A; Biomedical Research Institute INCLIVA, University of Valencia, Valencia Spain.
  • Chow LQ; University of Washington, Seattle, Washington.
  • Lesokhin AM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rutten A; Weill Cornell Medical College, New York, New York.
  • Sznol M; GasthuisZusters Antwerpen Sint-Augustinus, Antwerp, Belgium.
  • Rishipathak D; Yale School of Medicine, New Haven, Connecticut.
  • Chen SC; Genentech, Inc., South San Francisco, California.
  • Stefanich E; Genentech, Inc., South San Francisco, California.
  • Pourmohamad T; Genentech, Inc., South San Francisco, California.
  • Anderson M; Genentech, Inc., South San Francisco, California.
  • Kim J; Genentech, Inc., South San Francisco, California.
  • Huseni M; Genentech, Inc., South San Francisco, California.
  • Rhee I; Genentech, Inc., South San Francisco, California.
  • Siu LL; Genentech, Inc., South San Francisco, California.
Clin Cancer Res ; 28(16): 3452-3463, 2022 08 15.
Article in En | MEDLINE | ID: mdl-35699599
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lung Neoplasms / Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lung Neoplasms / Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Year: 2022 Document type: Article